Wellspring Financial Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$225K Buy
+2,490
New +$209K 0.01% 251
2022
Q2
Sell
-1,699
Closed -$200K 113
2022
Q1
$200K Hold
1,699
0.06% 91
2021
Q4
$220K Buy
+1,699
New +$198K 0.06% 94

Other funds holding EW

Wellspring Financial Advisors's EW Position: Q2 2026 in Review

Wellspring Financial Advisors opened a new position in Edwards Lifesciences (EW) in Q2 2026: 2,490 shares worth $225K. The stake represents 0.01% of the portfolio and ranks #251 among its holdings. This is a return to the name: Wellspring Financial Advisors previously reported a position in EW as recently as Q1 2022.

Wellspring Financial Advisors first reported a position in EW in Q4 2021 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Wellspring Financial Advisors held 2,490 shares of Edwards Lifesciences worth $225K as of Q2 2026.
  • Edwards Lifesciences was a new Wellspring Financial Advisors position in Q2 2026.
  • Edwards Lifesciences made up 0.01% of Wellspring Financial Advisors's portfolio in Q2 2026, its #251 holding.
  • Wellspring Financial Advisors first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 3 quarters since.
  • 327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Wellspring Financial Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.